Will never pursue 100% approval across the board for all cancers that can be used with Radiogel. That's not how medical market works. Once Radiogel is approved for one or a few cancers, most of the market will be off label uses, hence no need to seek approval for all cancers. But speculating that far down road is way beyond scope of this forum, cuz RDGL will be bought out if approved for one cancer if not beforehand on positive clinical trial data alone. Hence my laser focus on IDE. No human trials means end of story for RDGL.
News 
Market Data 
Discover 
